MENU
+Compare
FRES
Stock ticker: NASDAQ
AS OF
Dec 23 closing price
Price
$0.85
Change
-$0.27 (-24.11%)
Capitalization
2.08M

FRES Fresh2 Group Limited Forecast, Technical & Fundamental Analysis

a biotechnology company, which engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology.

Industry Biotechnology
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FRES with price predictions
Jan 08, 2025

FRES's RSI Indicator stays in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on FRES as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FRES advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

FRES may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FRES turned negative on December 19, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRES declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FRES entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.165) is normal, around the industry mean (15.127). P/E Ratio (0.000) is within average values for comparable stocks, (88.131). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.798). FRES has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.900) is also within normal values, averaging (264.117).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FRES’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRES’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
650 5TH Avenue
Phone
+1 917 397-6890
Employees
75
Web
https://www.fresh2.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPCB9.741.04
+11.95%
SuperCom Ltd
IONQ32.332.08
+6.88%
IonQ
TRML19.70-0.30
-1.50%
Tourmaline Bio
OWL22.55-0.69
-2.97%
Blue Owl Capital
ATRA15.55-0.98
-5.93%
Atara Biotherapeutics Inc.

FRES and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
N/A
HOOK - FRES
75%
Closely correlated
+15.59%
KZIA - FRES
57%
Loosely correlated
-6.51%
NKTR - FRES
34%
Loosely correlated
-9.65%
QURE - FRES
32%
Poorly correlated
-13.00%
KPRX - FRES
31%
Poorly correlated
-5.43%
More

Groups containing FRES

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
N/A
FRES
(2 stocks)
69%
Closely correlated
+7.80%
Medical Specialties
(439 stocks)
-1%
Poorly correlated
-0.07%